OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Princess Ghida Talal Honored Professor Nizar Tannir with the Award for Excellence in Cancer Research - KHCC

International Lung Cancer Summit 2026: From Molecular Targets to the Next Era of Precision Thoracic Oncology

Julio Delgado: Hospital Clínic Barcelona Launches First CAR-T Clinical Trial for HER2+ Breast Cancer

Françoise Meunier: New Milestone for the Right to Be Forgotten 

Amer Zeidan Receives 2026 King Hussein Cancer Research Lifetime Achievement Award

Hidden Basal-Like Cells in Luminal Breast Cancer: Nature Study Reveals New Epigenetic Signals of Recurrence

Gevorg Tamamyan: Celebrating a Life That Changes Lives

Aman Chauhan: Real-World Outcomes and Safety of Tarlatamab in Small Cell Lung Cancer

Immune Oncology

OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.